Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
CiToxLAB
CiToxLAB
Activities:
Regulatory
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Graphs and graph data science in drug discovery
Life sciences data expert Dr Alexander Jarasch discusses what work being done at the Institut de Recherches Servier can teach us about using modern data technologies for early...
Why smaller CDMOs should enhance their operational efficiency now: a CPHI expert guide
CPHI experts advise smaller CDMO's to invest in supply chain resilience, friend shoring and AI to keep up with the predicted uptick in funding for 2025
CPI collaborates with industry leaders to expedite drug manufacturing via digitisation
Digitising manufacturing technologies could allow enhanced ability to scale production, reduce costs and expedite the process
Janssen to adopt Johnson & Johnson brand as the company celebrates 100 years of UK operation
The company's pharmaceutical and medical technology segments will combine under the Johnson & Johnson brand name in the UK
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Research & Development
CiToxLAB hires Alan Bartlett as Senior Director, Global Laboratory Operations
Bartlett will be based at the contract research organisation's Laval site in North America
Research & Development
CiToxLAB hires Senior Director of Biomarkers
Philippe Ancian returns to the French contract research organisation
Research & Development
CiToxLAB appoints John Kapeghian as Senior Director of Toxicology in North America
Boosts company’s expertise in preclinical development and regulatory affairs
Research & Development
CiToxLAB expands inhalation test capabilities in North America and Europe
Opens rodent and non-rodent facility in Canada and will double rodent capacity in Hungary
Research & Development
CiToxLAB increases capabilities in reprotoxicology and juvenile studies
Appoints Paul Barrow as director of scientific projects and client consulting
Regulatory
CiToxLAB emerges from CIT and LAB Research merger
Will provide pre-clinical and specialist services from four facilities
Regulatory
CIT acquires assets of LAB Research Inc
This acquisition makes the new group one of the world’s top preclinical CROs
Subscribe now